Colin Begg (statistician) explained

Colin B. Begg
Nationality:Scottish
Fields:Biostatistics, epidemiology
Workplaces:Memorial Sloan-Kettering Cancer Center
Alma Mater:University of Glasgow
Thesis Title:Statistical diagnosis
Thesis Year:1976
Doctoral Advisor:John Aitchison

Colin B. Begg is a Scottish biostatistician and epidemiologist. He is an attending biostatistician at the Memorial Sloan-Kettering Cancer Center in New York City.[1] He serves as editor-in-chief of the journal Clinical Trials.[2] He has conducted research on the role of BRCA genetic variants in the development of breast cancer,[3] [4] as well as racial disparities in cancer survival rates in the United States.[5]

Begg was named a Fellow of the American Statistical Association in 1996.[6]

Notes and References

  1. Web site: Colin Begg . Memorial Sloan Kettering Cancer Center . en . 2018-12-07.
  2. Web site: Clinical Trials . SAGE Journals . en . 2018-12-07.
  3. Web site: Breast cancer genes don't have to mean cancer . 2008-01-09 . New Scientist . en-US . 2018-12-07.
  4. Web site: Scary Statistics . Alpert . Bill . 2002-10-21 . Barron's . en-US . 2018-12-07.
  5. News: Racial Gap in Cancer Survival Is Not Biological, Study Finds . Reuters . 2002-04-24 . The New York Times . 2018-12-07 . en-US . 0362-4331.
  6. Web site: ASA Fellows list. American Statistical Association. 2021-11-03.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Colin Begg (statistician)".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.